A look at this week's top stories.
A study published in the journal Sleep and Breathing found sleep quality influenced newborn weight in a gender-specific and trimester-specific way.
A review of the risks, benefits, and indications for appropriate referral of fetal echocardiography
An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.
Understanding the effects is imperative for patient satisfaction.
In an effort to identify abnormal bleeding patterns and their prevalence and confirm existing and expected associations, a study was conducted as part of Apple’s larger Women’s Health Study.
Fertility myths and declining sexual satisfaction may contribute to shortfalls in contraceptive use after cancer treatment, a new study concludes.
Women in the late reproductive stage may experience menopause-related symptoms that could impact their quality of life, according to new research.
Labels of Plan B One-Step had previously stated—without scientific evidence—that the pill might block fertilized eggs from implanting in the womb.
The Food and Drug Administration (FDA) has approved another Tdap vaccine option for use during pregnancy to prevent pertussis, otherwise known as whooping cough.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More